Expert Insights: Unlocking next generation gene therapies
Assessing cardiotoxicity of a highly selective novel MCL1 inhibitor with iPSC-derived models
Expert Insights: From animal to iPSC-derived models, a new era in preclinical evaluation
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease